Tom Gallo, president of the Association of Community Cancer Centers, discusses how burnout is on the rise, but being better addressed now, as well as how technology can both contribute to and alleviate burnout.
Tom Gallo, president of the Association of Community Cancer Centers, discusses how burnout is on the rise, but being better addressed now, as well as how technology can both contribute to and alleviate burnout.
Transcript
What is the difference between how burnout used to be addressed compared with now?
I don’t think it was addressed in the past, to be honest with you. I do think that there is probably more physician burnout today due to the increasing complexity of cancer care, as well as the increasing complexity of the healthcare system, itself, just in terms of reimbursement and authorization for treatment, and just the complexity of care with the new advances in care. I think burnout, itself, is on the rise. We have more cancer patients, more survivors, more people to take care of. On the positive side, cancer patients are living longer, but again, we’re seeing a bigger patient burden put on a limited number of physicians.
How can technology be both a burden that attributes to burnout, but also something that can alleviate burnout?
I think technology can be part of the solution and I think there is the promise that it can be part of the solution at some point in the future. There are however, a lot of additional tasks that physicians have to do with the EHRs, and the inability of the different systems to speak to each other and transfer data between systems is a problem.
As an example, my physicians in our practice, we have an oncology specific EHR, but then we also see patients in a multi-hospital system, and each one of those hospital systems has their own EHR, and they’re different. So we have physicians who have to now 3 or 4 separate EHR functionalities and processes in order to get through their day seeing the patients. It’s difficult.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More